Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Etractive of fenugreek and its producing method

A production method and technology of fenugreek, applied in the directions of chemical instruments and methods, drug combinations, pharmaceutical formulations, etc., can solve the problems of no complication treatment, high treatment failure rate, patients cannot achieve expected results, etc., and reduce blood viscosity. , enhance insulin sensitivity, and protect the effect of acute cerebral ischemia injury

Inactive Publication Date: 2004-03-10
XINJIANG TEFENG PHARMA +1
View PDF0 Cites 18 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In recent years, the secondary failure of oral hypoglycemic drugs has become more and more obvious. The main reason for the secondary failure of sulfonylureas is the decreased sensitivity of patients to insulin. They can only control blood sugar in 60%-70% of diabetic patients. However, persistently high blood sugar levels and severe obesity make patients hardly achieve the expected results. In addition to the relatively high initial treatment failure rate, about 10% of patients do not respond to treatment each year and are not used for the treatment of complications.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Example 1, the fenugreek extract contains 20% total fenugreek saponins by weight percentage.

Embodiment 2

[0023] Example 2, the fenugreek extract contains 30% total fenugreek saponins by weight percentage.

Embodiment 3

[0024] Example 3, the fenugreek extract contains 40% total fenugreek saponins by weight percentage.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A feungreek extract containing the common saponin of feungreek for preventing and treating diabetes and its chronic complications is prepared through extracting with alcohol, macroreticular adsorption, washing for removing impurities, eluting, concentrating the eluting liquid, and drying.

Description

technical field [0001] The present invention relates to an extract extracted from fenugreek plants and its extraction method, which is a fenugreek extract and its production method and its application in the preparation of medicines with regulating effect on blood sugar and blood lipid in the treatment of diabetes. Luba extract especially has the effect of preventing and treating diabetes (DM) and chronic complications of diabetes (DM), and has a regulating effect on blood sugar and blood lipid. Background technique [0002] The traditional Chinese medicine fenugreek is the seed of fenugreek (Trigonella foenum-graecum L), also known as fenugreek, which is a special product of Xinjiang Uygur Autonomous Region. Extensive and rich in resources, it is also a kind of medicinal and edible plant commonly used in traditional Chinese medicine and Uighur medicine. Uighur medicine believes that it has the effect of refreshing the brain and prolonging life. In ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7048A61P3/10C07G3/00C07J71/00
Inventor 李琳琳毛新民杨卫星张月明李世强王雪飞冉新建杨永新孙晓风王海燕李念东邬利娅白丽
Owner XINJIANG TEFENG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products